ASSEMBLY BIOSCIENCES, INC.
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
ASMB$21.79+6.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
(a)Exhibits. The following exhibits are filed or furnished, as applicable, as part of this quarterly report on Form 10-Q:
| ExhibitNumber | Description of Document | FiledHerewith | Incorporatedby Referencefrom | Date | Number |
|---|---|---|---|---|---|
| 4.1 · Form of Class A Warrant. · X | |||||
| 4.2 · Form of Class B Warrant. · X | |||||
| 4.3 · Form of Pre-Funded Warrant. · X | |||||
| 4.4 · Private Placement Class A Warrant. · X | |||||
| 4.5 · Private Placement Class B Warrant. · X | |||||
| 10.1 | Securities Purchase Agreement, dated August 8, 2025, by and between Assembly Biosciences, Inc. and Gilead Sciences, Inc. | Form 8-K | 08/11/2025 | 10.1 | |
| 31.1 | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 31.2 | Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.1* | Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.2* | Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 101.INS | Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRLtags are embedded within the Inline XBRL document | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | |||
| 104 | Cover page formatted as inline XBRL and contained in Exhibits 101 | X | |||
- The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is to be deemed furnished and shall not be deemed “filed” with the SEC and is not to be incorporated by reference into any filing of Assembly Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.